Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-κB

Inflammation

Volumn 24, Issue 5, 2000, Pages 385-398

  Choi, Jung Hwa ^a   Chung, Woon Jae ^a   Han, Su Ji ^a   Lee, Hwanghee Blaise ^a   Choi, Il Whan ^b   Lee, Hern Ku ^b   Jang, Kyu Yun ^b   Lee, Dong Geun ^b   Han, Sang Seop ^c   Park, Kyung Hwa ^d   Im, Suhn Young ^a  

^a Chonnam National University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

^d Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; CARBAMIC ACID DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE; SUCCINIC ACID; THROMBOCYTE ACTIVATING FACTOR; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME MECHANISM; FEMALE; GENE ACTIVATION; GENE EXPRESSION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN INDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; AZEPINES; BENZOQUINONES; DISSEMINATED INTRAVASCULAR COAGULATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENISTEIN; HEMORRHAGE; HYDROGEN PEROXIDE; I-KAPPA B PROTEINS; ISOFLAVONES; KIDNEY MEDULLA; LACTAMS, MACROCYCLIC; LETHAL DOSE 50; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PHOSPHORYLATION; PLATELET ACTIVATING FACTOR; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-TYROSINE KINASES; PULMONARY EDEMA; PYRROLIDINES; QUINONES; REACTIVE OXYGEN SPECIES; SERINE PROTEINASE INHIBITORS; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; SUCCINIC ACID; THIOCARBAMATES; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN E;

ANIMALIA;

EID: 0033936596     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007068010645     Document Type: Article

References (45)

1. 1. GAY, J. C. 1993. Mechanism and regulation of neutrophil priming by platelet-activating factor. J. Cell. Physiol. 156:189-197.
2. 2. FUKUDA, A. I., and K. F. BREUEL. 1996. Effect of platelet-activating factor on embryonic development and implantation in the mouse. Hum. Reprod. 11:2746-2749.
3. 3. SHUKLA, S. D. 1992. Platelet-activating factor receptor and signal transduction mechanisms. FASEB J. 6:2296-2301.
4. 4. BUTTKE, T. M., and P. A. SANDSTROM. 1995. Redox regulation of programmed cell death in lymphocytes. Free. Radic. Res. 22:389-397.
5. 5. BRAQUET, P., L. TOUQUI, T. Y. SHEN, and B. B. VARGAFTIG. 1987. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39:97-145.
6. 6. BARNES, P. J. 1992. PAF, eosinophils and asthma. J. Lipid. Mediat. 5:155-158.
7. 7. BRAQUET, P., A. ETIENNE, C. TOUVAY, R. H. BOURGAIN, J. LEFORT, and B. B. VARGAFTIG. 1985. Involvement of platelet-activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN52021. Lancet 1(8444): 1501.
8. 8. IM, S. Y., H. M. KO, Y. S. KO, J. W. KIM, H. K. LEE, T. Y. HA, H. B. LEE, S. J. OH, S. BAI, K. C. CHUNG, Y. B. LEE, H. S. KANG, and S. B. CHUN. 1996. Augmentation of tumor metastasis by platelet-activating factor. Cancer Res. 56:2662-2665.
9. 9. BENNETT, S. A., L. C. LEITE, and H. C. BIRNBOIM. 1993. Platelet-activating factor, an endogenous mediator of inflammation, induces phenotypic transformation of rat embryo cells. Carcinogenesis 14:1289-1296.
10. 10. GELBARD, H. A., H. S. NOTTET, S. SWINDELLS, M. JETT, K. A. DZENKO, P. GENIS, R. WHITE, L. WANG, Y. B. CHOI, D. ZHANG, et al. 1994. Platelet-activating factor: a candidate human immunodeficiency virus type I induced neurotoxin. J. Virol. 68:4628-4635.
11. 11. CHOI, I. H., T. Y. HA, D. G. LEE, J. S. PARK, J. H. LEE, Y. M. PARK, and H. K. LEE. 1995. Occurrence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor. Clin. Exp. Immunol. 100:390-394.
12. 12. HANDLEY, D. Y., R. G. VAN VALEN, M. K. MELDEN, and R. N. SAUNDERS. 1984. Evaluation of dose and route effects of platelet-activating factor-induced extravasation in the guinea pig. Thromb. Haemostos. 52:34-36.
13. 13. IM, S. Y., S. J. HAN, H. M. KO, J. H. CHOI, S. B. CHUN, D. G. LEE, T. Y. HA, and H. K. LEE. 1997. Involvement of nuclear factor-κB in platelet activating factor-mediated tumor necrosis factor-α expression. Eur. J. Immunol. 27:2800-2804.
14. 14. HAN, S. J., J. H. CHOI, H. M. KO, I. W. CHOI, H. K. LEE, O. H. LEE, and S. Y. IM. 1999. Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. Eur. J. Immunol. 29:1334-1341.
15. 15. FANTONE, J. C., and P. A. WARD. 1982. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol. 107:397-418.
16. 16. VALONE, F. M., and E. J. GOETZL. 1983. Specific binding by human polymorphonuclear leukocytes of the immunological mediator I-O hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. Immunology 48:141-149.
17. 17. CHANEZ, P., G. DENT, T. YUKAWA, P. J. BARNES, and K. F. CHUNG. 1990. Generation of oxygen free radicals from blood eosinophils from asthma patients after inflammation with PAF or phorbol ester. Eur. Respir. J. 3:1002-1007.
18. 18. HARTUNG, H. P., M. J. PARNHAM, J. WINKELMANN, W. ENGLBERGER, and U. HADDING. 1983. Platelet-activating factor (PAF) induces the oxidative burst in macrophages. Int. J. Immunopharmacol. 5:115-121.
19. 19. KATO, M., K. TOKUYAMA, A. MORIKAWA, T. KUROUME, and P. J. BARNES. 1993. Platelet-activating factor-induced enhancement of superoxide anion generation in guinea pigs. Eur. J. Pharmacol. 232:7-12.
20. 20. SEN, C. K., and L. PACKER. 1996. Antioxidant and redox regulation of gene transcription. FASEB J. 10:709-720.
21. 21. KUROKI, M., E. E. VOEST, S. AMANO, L. V. BEEREPOOT, S. TAKASHIMA, M. TIOLENTINO, R. Y. KIM, R. M. ROHAN, K. A. COLBY, K. T. YEO, and A. P. ADAMIS. 1996. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest. 98:1667-1675.
22. 22. GEVA, E., B. BARTOOV, N. ZABLUDOVSKY, J. B. LESSING, L. LERNER-GEVA, and A. AMIT. 1996. The effect of antioxidant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil. Steril. 66:430-434.
23. 23. CAYOTA, A., F. VUILLIER, G. GONZALEZ, and G. DIGHIERO. 1996. In vitro antioxidant treatment recovers proliferative responses of anergic CD4+ lymphocytes from human immunodeficiency virus-infected individuals. Blood 87:4746-4753.
24. 24. SCHAUER, U., C. LEINHAAS, R. JAGER, and C. H. RIEGER. 1991. Enhanced superoxide generation by eosinophils from asthmatics children. Int. Arch. Allergy. Appl. Immunol. 96:317-321.
25. 25. PALLER, M. S., J. R. HOIDAL, and T. F. FERRIS. 1984. Oxygen free radicals in ischemic acute renal failure in the rat. J. Clin. Invest. 74:1156-1164.
26. 26. CUEVA, J. P., and W. HSUEH. 1988. Role of oxygen-derived free radicals in platelet-activating factor-induced bowel necrosis. Gut 24:1207-1212.
27. 27. EMANUELLI, G., G. MONTRUCCHIO, E. GAIA, L. DUGHERA, G. CORVETTI, and L. GUBETTA. 1989. Experimental acute pancreatitis induced by platelet-activating factor in rabbits. Am. J. Pathol. 134:315-326.
28. 28. NOVELLI, G. P. 1997. Role of free radicals in septic shock. J. Physiol. Pharmacol. 48:517-527.
29. 29. BAEUERLE, P. A., and T. HENKEL. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
30. 30. BAEUERLE, P. A., and D. BALTIMORE. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53:211-217.
31. 31. KOPP, E., and S. GHOSH. 1994. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58:1-27.
32. 32. HALLIWELL, B., and J. M. GUTTERIDGE. 1989. In: Free Radicals in Biology and Medicine. Clarendon Publishers, Oxford, UK.
33. 33. SCHIEVEN, G. L., J. M. KIRIHARA, D. E. MYERS, J. A. LEDBETTER, and F. M. UCKUN. 1993. Reactive oxygen intermediates activate NF-κB in a tyrosine kinase dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes. Blood 82:1212-1220.
34. 34. NAKAMURA, K., T. HORI, N. SATO, K. SUGIE, T. KAWAKAMI, and J. YODOI. 1993. Redox regulation of a src family protein tyrosine kinase p56lck in T cells. Oncogene 8:3133-3139.
35. 35. HENKEL, T., T. MACHLEIDT, I. ALKALAY, M. KRONKE, Y. BEN-NERIAH, and P. A. BAEUERLE. 1993. Rapid proteolysis of IκBα is necessary for activation of transcription factor NF-κB. Nature 365:182-185.
36. 36. MACKMAN, N. 1994. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J. Biol. Chem. 269:26363-26367.
37. 37. FLOHE, L., R. BRIGELIUS-FLOHE, C. SALIOU, M. G. TRABER, and L. PACKER. 1997. Redox regulation of NF-κB activation. Free. Radi. Biol. Med. 22:1115-1126.
38. 38. MEYER, M., H. L. PAHL, and P. A. BAEUERLE. 1994. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem. Biol. Interact. 91:91-100.
39. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J. Biol. Chem. 265:2896-2902.
40. 40. HARDWICK, J. S., and B. M. SEFTON. 1995. Activation of the Lck tyrosine protein kinase by hydrogen perioxide requires the phosphorylation of Try 394. Proc. Natl. Acad. Sci. U.S.A. 92:4527-4531.
41. 41. SINGH, S., and B. B. AGGARWAL. 1995. Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B. J. Biol. Chem. 270:10631-10639.
42. 42. BALDWIN, A. S. 1996. The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14:649-681.
43. 43. ROFF, M., I. THOMPSON, M. S. RODRIGUEZ, I. M. JACQUC, F. BALEUX, F. ARENZANA-SEISDEDOS, and R. T. HAY. 1996. Role of IκBα ubiquitination in signal-induced activation of NF-κB in vivo. J. Biol. Chem. 271:7844-7850.
44. 44. IMBERT, V., R. A. RUPEC, A. LIVOLSI, H. L. PAHL, B-M. TRAENCKNER, C. MUELLER-DIECKMANN, D. FARAHIFAR, B. ROSSI, P. AUBERGER, P. A. BAEUERLE, and J-F. PEYRON. 1996. Tyrosine-phosphorylation of IκBα activates NF-κB without proteolytic degradation of IκBα. Cell 86:787-798.
45. 45. GHOSH, S., and D. BALTIMORE. 1990. Activation of in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678-682.